Munich, Germany

Slavoljub Milosevic

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Slavoljub Milosevic: Innovator in T Cell Receptor Technology

Introduction

Slavoljub Milosevic, an accomplished inventor based in Munich, Germany, has made significant strides in the field of immunotherapy, particularly in the realm of T cell receptor technology. With a collection of seven patents to his name, his work centers on advancing the potential of T cell therapies, a promising area for cancer treatment and other diseases.

Latest Patents

Among his latest innovations, Milosevic has developed a patent for "Inducible T cell receptors and uses thereof," which details combinations of nucleic acid molecules that encode for TCR alpha and beta chains linked to dimerization domains. This invention not only enhances our understanding of T cell receptors but also presents various potential applications in therapeutic settings. Another notable patent is the "Enrichment of T cells using an anti-Cβ antibody," which outlines methods for enriching T cells that express specific recombinant T cell receptors by targeting the Cβ1 or Cβ2 chain. This advancement highlights his focus on improving the efficacy of T cell therapies.

Career Highlights

Slavoljub Milosevic has worked with prestigious organizations, including Medigene Immunotherapies GmbH and Helmholtz Zentrum München, which is part of the German Research Center for Environmental Health. His contributions to these institutions have been influential in pushing the boundaries of what is achievable in T cell therapy and immunotherapy research.

Collaborations

Throughout his career, Milosevic has collaborated with notable peers, including Dolores Schendel and Christian Ellinger. These collaborations have helped further the development of innovative therapies and fostered an environment of shared scientific pursuit in the field of immunology.

Conclusion

Slavoljub Milosevic exemplifies the spirit of innovation in the scientific community, particularly within the domain of T cell receptor technology. His patents and collaborations reflect a dedication to improving therapeutic options for various medical conditions, marking him as a significant contributor to ongoing research and development in immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…